MCM
SMTI icon

MAI Capital Management’s Sanara MedTech SMTI Stock Holding History

MAI Capital Management’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$207 Buy
12
+11
+1,100% +$226 ﹤0.01% 4613
2025
Q4 		$24 Buy
+1
New +$26 ﹤0.01% 4303

Other funds holding SMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

MAI Capital Management's SMTI Position: Q1 2026 in Review

MAI Capital Management increased its Sanara MedTech (SMTI) stake by 1,100% in Q1 2026, buying an estimated $226 and bringing the position to 12 shares worth $207. The position accounts for ﹤0.01% of the portfolio, ranked #4613.

MAI Capital Management first reported a position in SMTI in Q4 2025 and has held it in 2 quarters since. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

  • MAI Capital Management held 12 shares of Sanara MedTech worth $207 as of Q1 2026.
  • MAI Capital Management bought 11 Sanara MedTech shares in Q1 2026, an estimated $226.
  • Sanara MedTech made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #4613 holding.
  • MAI Capital Management first reported a position in Sanara MedTech in Q4 2025 and has held it in 2 quarters since.
  • 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.